Single Cell Bioinformatics Software and Services Market: By Component, By Application, Microbiology Others), By End User and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Single Cell Bioinformatics Software and Services Market Size, Share, Growth, Trends, and Global Industry Analysis: By Component (Bioinformatics Software, Bioinformatics Services), By Application (Oncology, Immunology, Neurology, Non-invasive Prenatal Diagnosis (NIPD), Microbiology Others), By End User (Biopharmaceutical and Biotechnology Companies, Research and Academic Institutes Others) and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

1. Executive Summary
2. Global Single Cell Bioinformatics Software and Services Market Introduction
2.1. Global Single Cell Bioinformatics Software and Services Market – Taxonomy
2.2. Global Single Cell Bioinformatics Software and Services Market –Definitions
2.2.1. Component
2.2.2. Application
2.2.3. End User
3. Global Single Cell Bioinformatics Software and Services Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Single Cell Bioinformatics Software and Services Market Dynamic Factors - Impact Analysis
3.6. Global Single Cell Bioinformatics Software and Services Market – Competition Landscape
3.7. Epidemiology
4. Global Single Cell Bioinformatics Software and Services Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Single Cell Bioinformatics Software and Services Market, By Component, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.1. Bioinformatics Software
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Bioinformatics Services
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Single Cell Bioinformatics Software and Services Market Forecast, By Application, 2017-2021 and Forecast, 2021 – 2027 (Revenue, US$ Mn)
6.1. Oncology
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Immunology
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Neurology
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Non-invasive Prenatal Diagnosis (NIPD)
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Microbiology
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
7. Global Single Cell Bioinformatics Software and Services Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
7.1. Biopharmaceutical and Biotechnology Companies
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Research and Academic Institutes
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Single Cell Bioinformatics Software and Services Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Single Cell Bioinformatics Software and Services Market - Opportunity Analysis Index, By Component, Application, End User and Region, 2022-2028
9. North America Single Cell Bioinformatics Software and Services MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
9.1. By Component Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Bioinformatics Software
9.1.2. Bioinformatics Services
9.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Oncology
9.2.2. Immunology
9.2.3. Neurology
9.2.4. Non-invasive Prenatal Diagnosis (NIPD)
9.2.5. Microbiology
9.2.6. Others
9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Biopharmaceutical and Biotechnology Companies
9.3.2. Research and Academic Institutes
9.3.3. Others
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Single Cell Bioinformatics Software and Services Market - Opportunity Analysis Index, By  Component, Application, End User, and Country, 2022-2028
9.6. North America Single Cell Bioinformatics Software and Services Market Dynamics – Trends
10. Europe Single Cell Bioinformatics Software and Services Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
10.1. By Component Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Bioinformatics Software
10.1.2. Bioinformatics Services
10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Oncology
10.2.2. Immunology
10.2.3. Neurology
10.2.4. Non-invasive Prenatal Diagnosis (NIPD)
10.2.5. Microbiology
10.2.6. Others
10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Biopharmaceutical and Biotechnology Companies
10.3.2. Research and Academic Institutes
10.3.3. Others
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Single Cell Bioinformatics Software and Services Market - Opportunity Analysis Index, By  Component, Application, End User, and Country, 2022-2028
10.6. Europe Single Cell Bioinformatics Software and Services Market Dynamics – Trends
11. Asia-Pacific Single Cell Bioinformatics Software and Services Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
11.1. By Component Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Bioinformatics Software
11.1.2. Bioinformatics Services
11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Oncology
11.2.2. Immunology
11.2.3. Neurology
11.2.4. Non-invasive Prenatal Diagnosis (NIPD)
11.2.5. Microbiology
11.2.6. Others
11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Biopharmaceutical and Biotechnology Companies
11.3.2. Research and Academic Institutes
11.3.3. Others
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Single Cell Bioinformatics Software and Services Market - Opportunity Analysis Index, By  Component, Application, End User, and Country, 2022-2028
11.6. Asia-Pacific Single Cell Bioinformatics Software and Services Market Dynamics – Trends
12. Latin America Single Cell Bioinformatics Software and Services Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
12.1. By Component Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Bioinformatics Software
12.1.2. Bioinformatics Services
12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Oncology
12.2.2. Immunology
12.2.3. Neurology
12.2.4. Non-invasive Prenatal Diagnosis (NIPD)
12.2.5. Microbiology
12.2.6. Others
12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Biopharmaceutical and Biotechnology Companies
12.3.2. Research and Academic Institutes
12.3.3. Others
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Single Cell Bioinformatics Software and Services Market - Opportunity Analysis Index, By  Component, Application, End User, and Country, 2022-2028
12.6. Latin America Single Cell Bioinformatics Software and Services Market Dynamics – Trends
13. Middle East and Africa Single Cell Bioinformatics Software and Services Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
13.1. By Component Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Bioinformatics Software
13.1.2. Bioinformatics Services
13.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Oncology
13.2.2. Immunology
13.2.3. Neurology
13.2.4. Non-invasive Prenatal Diagnosis (NIPD)
13.2.5. Microbiology
13.2.6. Others
13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Biopharmaceutical and Biotechnology Companies
13.3.2. Research and Academic Institutes
13.3.3. Others
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Single Cell Bioinformatics Software and Services Market - Opportunity Analysis Index, By Component, Application, End User, and Country, 2022-2028
13.6. MEA Single Cell Bioinformatics Software and Services Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Application& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Fluidigm Corporation
14.2.2. QIAGEN
14.2.3. Mission Bio
14.2.4. Illumina, Inc.
14.2.5. Takara Inc.
14.2.6. BD
14.2.7. PacBio
14.2.8. BioBam
14.2.9. IsoPlexis
15. Research Methodology
16. Key Assumptions and Acronyms

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

Key Market Players

  • Fluidigm Corporation
  • QIAGEN
  • Mission Bio
  • Illumina, Inc.
  • Takara Inc.
  • BD
  • PacBio
  • BioBam
  • IsoPlexis

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market